Personalized medicine involves the prescription of specific therapeutic agents (i.e. drugs) based on an individual's unique genomic composition or genotype. PdxBio™ offers products and services for the advancement of personalized medicine. An enabling requirement of personalized medicine is the availability of diagnostic tests with the ability to accurately determine the genotype of individuals. Essential requirements of such genotyping diagnostic tests are that they be exquisitely accurate, highly sensitive and affordable. The unique products offered by PdxBio™ satisfy these requirements.
The suite of proprietary technologies developed at PdxBio™ provides the capability of quantitative simulation of multiplex nucleic acid diagnostic assays performed on microarrays or in solution formats. Proprietary algorithms are based upon rigorous statistical thermodynamic analysis and system-wide treatment of all nucleic acid components present in a multiplex hybridization reaction. Our suite of algorithmic software supplies a firm analytical basis upon which to develop performance standards for microarray assays, and identify potential pitfalls in assay design and performance, without ever having to do an actual experiment. This results in superior assay performance and substantial savings in both physical and human resources. In addition, our analytical platform provides firm design strategies for in-house development and optimization of specific nucleic acid diagnostic assays based on multiplex hybridization.
As a business, PdxBio™ offers both software and hardware products for genomic analysis, assay design and engineering, and provides services for specialized assay development and interpretation.
Copyright 2007 © Portland Bioscience, Inc. All rights reserved.